TOKYO--(BUSINESS WIRE)--Kaneka Corporation (TOKYO: 4118) (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka) received U.S.-FDA *1 approval in April 2020 for its new brain aneurysm Embolization ...
TOKYO--(BUSINESS WIRE)--Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka; hereinafter "Kaneka"), Bacchus Bio innovation Co., Ltd ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results